The phosphoprotein DARPP-32 (dopamine and cyclic adenosine 3', 5'-monophophate-regulated phosphoprotein 32kDa) plays a central role in mediating the actions of a variety of neurotransmitters in medium spiny neurons of the striatum Fienberg, et al., 1998) . This study examines D1 and D2 DA agonist effects on the membrane properties of identified striatal neurons recorded in slices obtained from wildtype and DARPP-32 -knockout mice. In wildtype spiny cells, DA D1 receptor activation decreased cell excitability, causing a 58.8 ±13.5% increase in rheobase current required to evoke spike discharge. In contrast, D1 agonist administration did not alter cell excitability when applied to spiny cells in slices prepared from the DARPP-32 knockout mice. D2 agonist administration decreased cell excitability in both wildtype and knockout mice. The response produced by combined D1 and D2 agonist stimulation was dependent on the sequence of agonist administration. Thus, the D1 agonist-induced decrease in excitability was reversed to a facilitation of spiking upon subsequent D2 agonist administration. In contrast, D2 agonist applied simultaneously with the D1 agonist only produced a reduction in excitability. This type of D1-dependent modulation was not present in slices from the DARPP-32 knockout mice.
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5 5 enkephalin-containing (Barrett et al., 1992) striatal cells that are thought to contain primarily the D2 receptor subtype (Robertson et al., 1992; Hersch et al., 1995) . In contrast to D1 receptors, D2 receptor stimulation dephosphorylates DARPP-32 by activating calcineurin via calcium influx (Greengard, 1990; Nishi et al., 1997) . DARPP-32 protein is present in all striatal efferent pathways, including the globus pallidus, the entopeducular nucleus, and the substantia nigra (Lindskog, et al., 1999) . Thus, DA modulation of DARPP-32 has the potential to subserve an integrating function with respect to the regulation of striatal outflow carried via both direct and indirect output pathways (Alexander and Crutcher, 1990; Smith et al., 1998) .
A potent tool that has been recently made available is the DARPP-32 knockout mouse, in which the gene encoding this protein has been eliminated (Fienberg et al., 1998) resulting in an attenuation of D1-mediated responses (Fienberg et al., 1998; Calabresi et al., 2000) . We have therefore used this animal model to examine the temporal interactions of identified striatal neurons to D1 and D2 agonist administration in slices prepared from wildtype versus DARPP-32 knockout mice. In particular, this study is aimed to examine the functional consequences of D1/D2 receptor activation dependent on the time course of the activation of two DA receptor subtypes. Portions of these data have been presented in abstract form (Onn et al., 1996; Grace et al., 1999) .
7 dissolving them in the oxygenated superfusate-containing reservoir bottle to achieve the specified working concentration. The drug-containing superfusate required approximately 1.5 minutes to reach the chamber and 3 minutes to completely replace the media within the chamber. The time of drug onset described in the results was calculated from the time that the perfusion lines were switched from the control physiological saline to the drug-containing superfusate. The sequential D2 co-application was typically administered via addition to the reservoir bottle between 10-15 minutes following the onset of D1 agonist administration.
Intracellular recording and labeling using neurobiotin-filled microelectrodes
Recording electrodes were constructed from 1 mm O.D. Omegadot (WPI, Sarasota, FL) borosilicate glass tubing using a Flaming-Brown P-80/PC electrode puller and filled with 2% Neurobiotin (dissolved in 3 M potassium acetate; average electrode impedance: 75-150 MΩ as measured in situ).
Intracellular recordings were performed using a NeuroData 383 intracellular preamplifier, with current injected across a bridge circuit integral to the preamplifier. All membrane potential values were adjusted by subtracting the tip potentials measured at the time point when electrodes were pulled out of cells recorded. The neurobiotin-filled microelectrodes were lowered into the middle region of the dorsal-ventral plane (with the exclusion of n. accumbens and the dorsalmost aspects of striatum) under visual control using a stereomicroscope (Nikon SMZ-2B) by referring to anatomical landmarks, including the anterior commissure, septum, cortical white matter, and internal capsule, with reference to a rat brain stereotaxic atlas (Paxinos and Watson, 1986) . After impalement of a cell, 2-5 nA constant hyperpolarizing current was applied to achieve a stable impalement; baseline physiological data were then collected at resting membrane potential in the absence of the hyperpolarizing current. After obtaining drug-induced responses, cells were injected with neurobiotin using 0.5-1 nA depolarizing current pulses delivered at 1-4
Hz . Only 1 cell per slice was injected in order to ensure an accurate correlation between pharmacological responses and cell morphology and location. The slices with neurobiotininjected cells were then postfixed with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) and cryoprotected in 20% sucrose solution before subjecting to a freeze-thaw procedure to facilitate the JPET#50062 8 8 penetration of the immunoreagents used for histochemical staining for neurobiotin. The histochemical reactions included a 24-hour incubation with avidin-biotinylate complex (Vector, CA) and a 30 min reaction with DAB solution (Vector, CA), with thorough rinsing with buffer between all steps. The slices were then cleared with 100% dimethylsulfoxide (DMSO) for 20 min and mounted in DMSO for microscopic examination (Grace and Llinas, 1985) . The neurobiotin-filled cells in DMSO-mounted slices were photographed using Kodak Ektachrome ASA 400 color slide film before being subjected to a subsequent dehydrating/defatting process with an alcohol series and xylene to allow mounting of the slices with protex for long-term storage and examination (Onn and Grace, 1994; .
Physiological measures of the recorded cells
The input resistance of the recorded cells was calculated by measuring the membrane voltage deflections produced in response to 100-150 msec duration constant hyperpolarizing current pulses (range:0.2-0.5nA) delivered across a bridge circuit integral to the preamplifier. Action potential amplitude was measured as the difference between spike threshold and peak of the spike evoked by depolarizing current pulses (150 msec duration) for within-subject comparisons of drug action.
When basic spike properties were compared between wildtype and knockout mice, spike amplitude was measured from the resting membrane potential for a between-subject comparison. Our previous studies have shown that the spike amplitude as measured from spike threshold is likely to lead to an underestimate of actual spike amplitude, since we reported that a GABAergic conductance located proximal to the spike initiation zone will shift the apparent spike threshold measured at the soma to more depolarized levels (Onn et al., 1994a) . Spike threshold was defined as the onset of the fast rising depolarizing phase of the action potentials. Action potential duration was measured across the rising and falling phases of the spike at the membrane voltage corresponding to spike threshold. The amplitude of the afterhyperpolarization following spikes was measured from the voltage corresponding to spike threshold on the falling phase of the spike to the point at which the membrane returned to resting potentials. Rheobase current, defined as the amplitude of current required to generate the first spike discharge, was used to assess the membrane excitability in conjunction with the JPET#50062 9 assessment of spike threshold. Data are presented as mean ± standard error of the mean (SEM) and the unpaired Student's t-test was used for between-subject comparison (i.e., between means of wildtype and knockout mice), whereas the paired Student's t-test was used for within-subject comparison (before and after drug application on the cell tested). Differences were considered to be statistically significant at p<0.05.
This article has not been copyedited and formatted. The final version may differ from this version. 
Results

Morphology and Physiological Properties of Striatal Spiny Neurons in Wildtype and DARPP-32
Homozygote Knockout Mice.
During recording, all but five striatal neurons (43/48) exhibited physiological properties consistent with the characteristics of the spiny cell class reported in vitro by others (Calabresi et al., 1987; 2000; Cepeda et al., 1993; O'Donnell and Grace, 1993) , including a high resting membrane potential, low input resistance and constant spike firing frequency upon depolarization. The cells did not exhibit fast spike discharge or low-threshold spikes, which are more typically associated with striatal interneurons (Kawaguchi, 1993; Onn and Grace, 1999) . The striatal aspiny cells encountered in this study, although infrequent (N=5), were not readily distinguishable from spiny cells during recording until subsequent observation of their distinct somatodendritic morphology following intracellular staining. Due to differences in their pharmacological responses when compared to spiny cells, the results obtained from recordings of these aspiny cells were not included in this report.
Given that the majority of DA terminals in the striatum form symmetrical synapses onto dendritic spines (Sesack et al., 1994 ) of the spiny neurons in which most DARPP-32 proteins are located , the morphology of the medium spiny neurons, as revealed by intracellular staining with neurobiotin, was verified for each cell in which pharmacological responses were recorded. Across both genotypes of mice, spiny neurons displayed similar membrane properties with respect to their resting membrane potential, input resistance, spike threshold, spike duration and spike amplitude for wildtype (N= 23) and homozygote (N=20) mice, respectively (Table 1) . Furthermore, a visual examination of the somatodendritic morphology of these physiologically identified spiny cells indicates that there were no gross differences between wildtype and mutant spiny cells (Figure 1A ,B; total N= 43), in terms of soma shape, somatodendritic field, number of primary dendrites, etc, and were similar to that previously described for medium spiny neurons in rat striatum in vivo (Onn et al., 1994b; Onn and Grace, 1994; .
Pharmacological Responses of Spiny Neurons to D1 Agonist (SKF38393) Administration
This article has not been copyedited and formatted. The final version may differ from this version. In general, bath application of the D1 agonist SKF 383933 (5-10 µM) to mouse striatal spiny cells (N=12) caused a decrease in excitability as revealed by a 58.8± 13.5 % increase in the average rheobase current required to evoke spiking compared to pre-drug values (D1: 0.89 ± 0.13 nA vs pre-D1: 0.58 ± 0.11 nA; pÀ1%0ÃUhiyrÃ!ÃUuvÃrssrpÃhÃiypxrqÃiÃurÃ9 ÃhhtvÃT8C!""(Ã$ÃµM; N=3). In examining the evoked activity in identified spiny cells (N=10; 5 for each control group), little accomodation of spike discharge was noted when comparing the first and the second interspike intervals in trains of spikes evoked upon injection of depolarizing pulses <1nA ( Figure 2A ). This firing pattern, which is characteristic of striatal spiny cells in rats (Calabresi et al., 1987; 2000; Cepeda et al., 1993; O'Donnell and Grace, 1996) , was not altered following bath application of the D1-agonist SKF 38393 ( Figure 2B ).
Spiny neurons that responded to D1 bath application with a decrease in membrane excitability also exhibited a decrease in action potential amplitude by 3.0 ±2.9mV, which is consistent with the reported D1-induced attenuation of sodium conductances by 37% (Schiffmann et al., 1995) . Although small changes in membrane potential, input resistance, spike threshold and amplitude were noted, due to the high degree of variability in these parameters when averaged across all cells before and after D1 agonist application in wildtype mouse slices, these D1-induced changes did not reach statistical significance (Table 3) . Thus, D1-induced decrease in membrane excitability in wildtype spiny cells was accompanied by a significant increase (58.8 ± 13.5 %; p<0.006) in rheobase current ( Figure 3) .
Analysis of the current-voltage relationship in the depolarizing direction revealed an inward rectification that was present in approximately 45% (5/11) of spiny cells tested prior to D1 agonist application. This rectification was not affected by D1 agonist application. There was no correlation between the presence of inward rectification and the response of the neurons to D1 agonist administration ( Figure 4 ; top panel). Thus, the presence or absence of inward rectification in the depolarizing direction is independent of the other D1-mediated effects as described above. As observed in spiny cells from wildtype mice, spiny cells in slices prepared from knockout mice responded to D1 agonist administration with a hyperpolarization of their membrane potentials (N= 7/12) that was similar in magnitude to that observed in wildtype neurons; nonetheless, the difference did not reach statistical significance in either case (knockout: hyperpolarized by 1.3 ± 1.1 mV vs wildtype: 2.7 ± 1.5mV; Table 3 ). Similarly, there were no significant differences noted in the input resistance (knockout; decreased by 3.0 ± 8.8 MΩ vs wildtype: increased by 25.3 ± 12.2MΩ; p = 0.71; N.S.), in the spike amplitude (knockout: -0.9 ± 2.2 mV vs wildtype: -3.0 ± 2.9mV; p = 0.57; N.S.) and in the spike threshold (knockout: decreased by 2.4 ±1.9 mV vs wildtype: increased by 5.2± 1.7mV; p = 0.29; N.S.), between wildtype and mutant spiny cells. However, the magnitude of D1-induced changes in the rheobase current (knockout: 1.5±4.1% vs wildtype: 58.8 ± 13.5%; *p = 0.0012, unpaired Student's t-test) were significantly smaller in mutant spiny cells than those observed in wildtype spiny cells (Table 3 ; Figure 3 ). In summary, mutant spiny cells typically responded to D1-like agonist application with negligible changes in resting membrane potential, input resistance, spike threshold and amplitude, and rheobase current. The inward rectification in the depolarizing direction that was present in 3 out of 8 mutant spiny cells was not altered by D1 agonist administration (Figure 4 ; bottom panel). In fact, the D1 agonist was found to enhance this property in 3 other mutant spiny cells that did not display this rectification prior to D1 agonist application.
Pharmacological Responses of Spiny Neurons to Combined D1 and D2 Agonist Administration
Wildtype
Application of the D2 agonist quinpirole caused a decrease in cell excitability (N=12) independent of whether it was administered alone (N= 6) or in combination with the D1 agonist (N= 6). Although D2 agonist administration did not cause consistent changes in membrane potentials (range=-10 mV to +11 mV) and resistances (-7MΩ to +5MΩ), it did result in an increase in spike threshold by 5-15 mV (avg.
= +7.8 ± 3.7mV) ( Figure 5 ; Table 4 ) when administered alone (N=6; +7.6 ± 3.8 mV) or with the D1 agonist (N=6; +8.1 ± 3.7mV), thus data from both groups were pooled. The large variability indicates that in either situation D2 inhibitory action was rather varied, e.g., from mild insignificant excitation/inhibition to a potent inhibition of membrane excitability and this may be a reflection of D2-mediated actions on both This article has not been copyedited and formatted. The final version may differ from this version. . Thus, as noted above the changes in membrane potentials were highly variable and did not approach statistical significance; however, changes in spike threshold and amplitude did occur consistantly and were independent of the change in membrane polarization. This decrease in membrane excitability was reflected by an average 47% increase in rheobase current (45 ± 39% for D2 alone; 51 ± 47% for D1& D2 combined; Table 4 ). Simultaneous application of D1/D2 agonists ( Figure 5B ) tended to cause a greater amplitude of membrane depolarization elicited by a given current pulse amplitude when compared to the agonist administered alone ( Figure 5A ).
Thus, D2 agonists when applied alone or simultaneously with D1 agonists produced a reduction in membrane excitability in wildtype spiny cells.
In slices (N=9) in which administration of SKF38393 resulted in a decrease in membrane excitability, subsequent co-administration of quinpirole (5-10 µM) at 10-15 minutes following SKF 38393 was found to restore the excitability of these cells to baseline levels (N=6/9). This was reflected by a D2-mediated restoration of spike threshold (-5.1±2.4mV) and threshold current (decreased by 63 ± 22% from the post-D1 levels) to the initial pre-drug levels (Table 4 ; Figure 6A1 -3). The average rheobase current observed following subsequent D2 agonist co-application (0.523 ± 0.135nA) was significantly lower than that observed following D1 application alone (0.89 ± 0.13 nA; *p<0.05), but was nearly identical to the initial (i.e., pre-D1 agonist) level (i.e., 0.58 ± 0.08 nA; p<0.4; N.S.; Table 2 ). Furthermore, the reduction in spike amplitude produced by D1 agonist application (-3.0 ±2.9 mV) was restored to initial (pre-drug) levels following subsequent D2 agonist administration (+2.7 ± 3.1 mV relative to post-D1 level; Table 4 ).
Mutant Spiny Cells The D2-induced reduction in membrane excitability in wildtype spiny cells, expressed as an increase in spike threshold and rheobase current (see above), was preserved in mutant spiny cells (N=8; 4 for D2 alone and 4 for combined D1/D2 agonists; spike threshold=+ 7.1 ± 2.3 mV and threshold current= +42 ±22%). Moreover, although D1 agonists failed to alter the excitability of cells recorded in slices from DARPP-32 knockout mice (see above), subsequent co-administration of the D2 agonist quinpirole also did not increase cell excitability (N=5), as it did in wildtype spiny cells. Thus, the This article has not been copyedited and formatted. The final version may differ from this version. 
DISCUSSION
Of the forty eight neurons labeled during recordings, data were analyzed from forty three neurons that were medium spiny in somatodendritic morphology. All of these neurons in normal mouse striatum were similar in somatodendritic morphology to spiny neurons labeled intracellularly in vitro in rat striatum or accumbens (Calabresi et al., 1987; 2000; Cepeda et al., 1993; O'Donnell and Grace, 1993) .
Furthermore, the basic membrane properties of knockout spiny neurons were similar to those of spiny neurons recorded in wildtype mouse slices. In contrast, in spiny neurons in the DARPP-32 knockout mice, stimulation of dopamine D1 receptors failed to produce the increase in spike threshold and threshold current observed in the wildtype. One apparent consequence of this loss of D1-mediated actions is that subsequent stimulation of D2 receptors in the knockout mouse slices produced qualitatively different responses from those typically observed in wildtype spiny neurons. Whether this modification is due to the loss of D1 modulation or instead is due to developmental and/or compensatory changes is unclear.
Nonetheless, these pharmacological data reveal a complex alteration in dopamine transmission in the DARPP-32 knockout mouse striatum.
Dopamine Modulation of Membrane Excitability in Spiny Neurons
Averaged across the population of medium spiny cells tested, D1 or D2 agonist administration did not significantly alter membrane potential. Nonetheless, administration of the D1 agonist SKF 38393 caused a 3-11 mV hyperpolarization in 62% of the cells tested, whereas administration of the D2 agonist quinpirole caused a 2-18 mV depolarization in 56% of the cells tested. Others have shown that DA acting via D1 receptor activation results in membrane hyperpolarization in striatal cells (Uchima et al., 1986; Calabresi et al., 1987) . In contrast, application of DA at higher concentrations (i.e., 100-400 µM) appears to depolarize striatal spiny neurons, presumably by a D2 receptor-induced decrease in potassium conductances (Uchima et al., 1986) . In the present study, we chose to use DA agonists applied at moderate doses (5-10 uM) as derived from the literature (Calabresi et al., 1987; 2000; Cepeda et al., 1993; 1995; O'Donnell and Grace, 1996) . Thus, activation of either dopamine receptor subtype reduced membrane This article has not been copyedited and formatted. The final version may differ from this version. agonist SKF 38393 with an increase in spike threshold and rheobase current, resulting in a suppression of spike discharge and a decrease in spike amplitude. These D1-induced changes are consistent with an alteration in sodium conductances. Dopamine is known to act on the slowly inactivating Na + and K + conductances to modulate the threshold current for evoking spikes in striatal neurons (Calabresi et al., 1987; Schiffmann et al., 1994; Cepeda et al., 1995) . This is believed to occur via the phosphorylation of sodium channels by the cAMP-dependent protein kinase A, resulting in a reduction in the open probability of sodium channels (Schiffman et al., 1994; Cepeda et al., 1995) . This is consistent with the apparent absence of D1-induced changes in spiny neurons recorded in knockout mouse slices in which the DARPP-32 proteins were absent. D1 agonists have also been reported to decrease N-and P-type while increasing L-type calcium currents in striatal cells via the DARPP-32 signal transduction pathway (Bargas et al., 1994) . However, L-type calcium channels appear to be activated by D1 receptors only when the cell membrane is depolarized to -50 mV or above (Hernandex-Lopez et al., 1997) , with the result being an excitatory response to D1 receptor activation. This D1-induced excitation at depolarized membrane potentials is proposed to result from co-activation of NMDA receptors (Cepeda et al., 1993) , thus is not likely to account for D1-induced increases in spike threshold and rheobase current observed in the present study.
Seventy percent of cells recorded in this study responded to either the D1-like and/or the D2-like agonist, suggesting that striatal spiny cells may exhibit either a high degree of D1 and D2 receptor colocalization (Surmeier et al., 1992; Hersch et al., 1995; Aizman et al., 2000) , or that these agonists exert influences on common sets of interneurons that innervate the spiny cells (Lindskog et al., 1999) . , 1987; Cepeda et al., 1995) superfusion buffer in which synaptic transmission is presumably blocked.
It appears that there is some residual D1 effect in the knockout spiny neuron that somehow modified the subsequent administration of the D2 agonist to enable a small excitatory action; nonetheless, the response was substantially less than that observed with D1 agonist administration in the wildtype neurons. In addition, the finding that the D2-induced reduction of membrane excitability persisted in the knockout spiny neurons suggests that signal transduction pathways other than the PKA-mediated DARPP-32 pathway may be involved in these responses.
Functional Implications of D1/D2 receptor interaction:
Our data indicate that simultaneous stimulation of D1 and D2 receptors causes a potentiated inhibition of striatal neuron activity, whereas D2 stimulation will reverse D1-mediated inhibition if applied at a later time. This arrangement may have functional implications with respect to the temporal regulation of striatal neurons by DA. Studies have shown that D1 and D2 receptors are located both intrasynaptically as well as along the extrasynaptic membrane of the neuron, with relatively higher numbers of D1 receptors located extrasynaptically and D2 receptors concentrated within the synaptic cleft (Smiley et al., 1992; Sesack et al., 1994; Khan et al., 1998) . Therefore, one would expect that a moderate activation of the DA system should lead to sufficient spike-dependent phasic DA release (Grace, 1991) to stimulate the intrasynaptic D2 receptors, thus leading to moderate inhibition of striatal neuron excitability. On the other hand, if the DA system is subjected to a powerful drive, such as during burst firing of DA neurons in response to reward-associated stimuli (Schulz, 1992; Wickens et al., 1996; Gonon, 1997) , the resultant massive phasic DA release (Grace, 1991) should be of sufficient magnitude to stimulate both D1 and D2
receptors within the synapse, as well as diffuse from the synapse to stimulate the extrasynaptic receptors. neurobiotin during recording from brain slices taken from wild type (A1,2), DARPP-32 homozygote (B1,2) knockout mice. Neurons exhibiting the electrophysiological characteristics representative of the spiny cell class were found to have similar gross morphological properties across both groups, e.g., dendritic spines and branching patterns, characteristic of medium spiny neurons in rat striatum (Onn et al., 1994b; Onn & Grace, 1994; . A1 and A2: photomicrographs of a wildtype spiny cell taken before (A1: DMSO mount) and after dehydration/defatting of the tissue (A2: protex mount). Although the spines were readily discernable in the DMSO-mounted preparation (A1), further examination of the same cell after mounting in protex (A2) enhanced the resolution of the spines despite the distortion of the dendritic processes caused by tissue shrinkage due to the dehydration process (Grace and Llinas, 1985) . B1 and B2:
Photomicrographs of a spiny cell that was recorded in a homozygote knockout mouse brain slice before (B1) and after (B2) dehydration/defatting. Photomicrographs shown here were taken on 350 um-thick sections. Calibration bar=10 µm. produced in response to the same amplitude of depolarizing current (A2). Nonetheless, because of the increase in spike threshold (A3: pre-drug threshold=-47mV; after D1 agonist=-39mV), higher amplitudes of current injection were required to elicit spike discharge after D1 agonist administration. In contrast, in the DARPP-32 knockout mice D1 agonist administration did not alter the resting membrane potential (B1:
-70mV before and after D1), the membrane voltage deflection produced by depolarization current injection (B2) or the spike threshold (B3: -50mV before and after D1). Traces in B1-3 marked by arrows were taken after D1 application. None of comparisons using a between-subject design reached statistical significance.
This article has not been copyedited and formatted. The final version may differ from this version. Data were expressed as mean ± S.E.M. **paired Student's t-test, p <0.006 as compared to pre-drug current in a within-subject design.
* paired Student's t-test, p <0.05 as compared to SKF38393 in a within-subject design.
# paired Student's t-test, N.S. as compared to pre-drug current in a within-subject design. 
